Abstract: Background: Immunosuppressive therapy, which is necessary to avoid graft rejection in renal transplant recipients, presents an increased risk of several pathologies, namely infectious and neoplastic. oBjectives: To identify the most frequent skin diseases and their clinical and demographical risk factors within a population of renal transplant recipients. Methods: A retrospective study of renal transplant recipients referred to dermatology visit and observed for the first time from January 2008 to December 2014. results: The study included 197 patients, 120 men (60,9%). Mean age was 50,7 years (±13,4). 12 patients (6,1%) had previous skin cancer. Infections were the most frequent reason of referral (93/197; 44%). From the total referred, 18,3% (36/197) presented pre-cancerous lesions. Malignancy was diagnosed in 36 patients (18,3%), with 29 non-melanoma skin cancers (14,7%) and 7 Kaposi sarcomas (3,6%). Ratio of basal cell carcinoma to squamous cell carcinoma was 1,1:1. Non-melanoma skin cancer was significantly associated with older age (p = 0,002), male gender (p = 0,028), history of previous skin cancer (p = 0,002) and higher duration of immunosuppressive therapy (p<0,001). study liMitations: Retrospective study, with data from the first visit in dermatology. We didn't made classification on skin-types. conclusions: The great incidence of cutaneous infections and skin cancer is responsible for a significant morbidity. It is important to assure the regular dermatological follow-up of renal transplant recipients, which will promote the prevention, an early diagnosis and an efficient treatment.
INTRODUCTION
In renal transplant, the use of immunosuppressive drugs, indispensable to avoid organ rejection, implies an increased risk of several infectious and neoplastic diseases.
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Cutaneous infections have a very high incidence in patients submitted to renal transplant and are diagnosed in 55-97% of these individuals. 2 The incidence of cutaneous neoplasia, particularly of non-melanoma skin cancer, is well characterized, with an increased risk of 20-times in the case of basal cell carcinoma (BCC) and 65-times in the case of squamous cell carcinoma (SCC). 3, 4 Cutaneous neoplasms appear at an earlier age and have a more aggressive behavior, with greater local invasiveness and a greater tendency to metastasize. 4, 5 Knowledge on the spectrum of skin diseases that most frequently affects patients undergoing renal transplant, in particular the understanding of their clinical presentation and their severity, is fundamental to elaborate dermatological follow-up plans in order to enhance their quality of life and increase their longevity.
The objectives of this study were to characterize a series of patients undergoing kidney transplantation and to identify the most frequent skin diseases when referring to the dermatology clinic. We also aimed to identify sociodemographic and clinical risk factors for diagnosed cutaneous neoplasms.
METHODS
We performed a retrospective study, including 223 patients who underwent renal transplant after 1979, referred to the specialist consultation on Dermatology for Transplanted Patients between January 2008 and December 2014. In that period, a total of 1,070 dermatology consultations were performed for transplanted patients, 223
were first-time consultations and 847 were subsequent consultations.
The sample is of convenience and is not representative of the population of renal transplant patients in Portugal. All patients aged <16 years (n = 1) and those who underwent bone marrow transplantation (n = 2) or liver transplantation (n = 5) were excluded. Those who were maintained on hemodialysis after transplant rejection (n = 2) or who were waiting for transplantation (n = 16) at the time of the first visit were also excluded. From the initial convenience sample, 26 patients were excluded, totaling 197 eligible patients for the study. Mann-Whitney test and chi-square test were used, with Cramer's V as a measure of association. Fisher's exact test was also used when any of the expected frequencies was less than five.
RESULTS
In this study, 197 renal transplant patients were included, 120 were men (60.9%) and 77 women (39.1%).
Patients' age at the time of the first consultation, after referral, ranged from 19 to 79 years, with a mean of 50.7 years and a median of 54 years (± 13.4 years).
Of the 197 patients in the sample, 167 were Portuguese (84.8%), 12 were Angolan (6.1%), 9 were Cape Verdean (4.6%), 4
were native from Guinea-Bissau (2.0%), 3 from São Tomé and Prín-cipe (1.5%), 1 from Moldova (0.5%) and 1 from England (0.5%).
Regarding race, 169 patients were Caucasian, Fitzpatrick were maintained in a three-drug regimen. Drugs used in the study sample are specified in table 1.
In 37 patients (18.8%), pre-neoplastic lesion or SCC in situ was diagnosed, with 27 cases of actinic keratosis (13.7%), 7 cases of Bowen's disease (3.6%), 3 cases of keratoacanthoma (1.5%), and 1 case of actinic cheilitis (0.5%). In one patient, simultaneous presence of actinic keratosis and Bowen's disease was observed.
In this study, actinic keratosis was significantly associated with Diagnosis of neoplasia was confirmed histologically in 36 patients (18.3%). There were 29 cases of non-melanoma skin cancer (14.7%) and 7 cases of Kaposi's sarcoma (3.6%). Of the 29 cases of non-melanoma skin cancer (14.7%), 16 were BCC (8.1%) and 15 were SCC (7.6%), with both diagnoses coexisting in two patients.
All cases of Kaposi's sarcoma were diagnosed in non-Caucasians, and no non-melanoma skin cancer or pre-neoplastic lesion was diagnosed in these patients.
Non-melanoma skin cancer was significantly associated with Diagnosis of fungal infection was made in 37 patients (18.8%), with 17 cases of dermatophytosis (8.6%), 15 of pityriasis versicolor (7.6%), five of pityrosporum folliculitis (2.5%), and two of candidiasis (1.0%). In one patient, the simultaneous diagnosis of dermatophytosis and candidiasis was made and, in another, dermatophytosis and pityriasis versicolor.
Bacterial infections were present in 10 patients (5.1%), as described in table 3.
Benign cutaneous tumors were observed as a reason for consultation in 31 patients (15.7%).
The diagnosis of inflammatory dermatosis was made in 23 patients (11.2%), and the pathologies observed are specified in table 4.
In six patients, an adverse drug reaction (3.0%) was observed, with 3 cases of acneiform eruption resulting from taking cor- ticosteroids (1.5%), 1 case of mouth ulcer (0.5%), 1 case of purpura (0.5%) and 1 case of toxin to tacrolimus (0.5%).
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In 25 patients, other dermatological conditions were diagnosed, not groupable in the previously specified categories (12.7%).
DISCUSSION
The present study allowed the characterization of the spectrum of skin diseases that motivated the referral to the Dermatology Clinic of Hospital Santa Maria in a series of renal transplant patients.
The main limitations of this study arise from the fact that this is a retrospective study, with data obtained through the analysis of records, and the fact that the sample is of convenience and there- In this study, therapy with regimens that included azathioprine was significantly associated with a higher incidence of viral infection. It is possible that this drug induces a more marked depletion in the number and function of Langerhans cells, a fact that justifies the relationship described and already verified in previous studies. 7, 8 In renal transplant patients, infections tend to have a more severe course, with a more rapid and more intense progression, generating abnormally severe and sometimes atypical conditions.
1,9
Thus, knowledge on the spectrum of the various forms of clinical presentation plays a pivotal role for early diagnosis and appropriate therapy. It may also be necessary to use preventive therapies, namely drugs and vaccines used prophylactically. 6 In this study, non-melanoma skin cancer accounted for 14.7% of referrals to the dermatology clinic. This value is similar to that obtained by Fernandes, S. et al., who, in a sample of renal transplant recipients, recorded an incidence of 13.3% of this neoplasm. 6 In the present series, non-melanoma skin cancer was significantly associated with age, male gender, longer duration of immunosuppressive therapy, and with previous cutaneous neoplasia.
In general population, a ratio of 4:1 between BCC and SCC is reported. In the transplanted patients, with time, there seems to be an exponential growth in incidence of SCC and a linear growth of BCC, so that the inversion of the ratio described is observed. 10 In this study, no such inversion was observed, with the number of BCC being greater than that of SCC, reaching a ratio of 1.1:1. This fact is in agreement with the data present in other studies conducted in the Mediterranean region, in which there seems not to be the typical inversion of the Anglo-Saxon and Scandinavian countries, probably due to genetic differences and sun exposure habits. 11, 12, 13 Although there is an increased risk of melanoma in the population of renal transplant patients by 1.6 to 3.4 times in the European territory, 4 in this series, there was no diagnosis of any case of this neoplasia.
Pre-neoplastic lesions were also an important reason for consultation in this study (18.8%), especially actinic keratosis, responsible for 13.7% of the referrals. This value differs from others from studies conducted in the Portuguese population. On the one hand, it is superior to data from the study of Fernandes, S. et al., in which the incidence of this pathology was 5% in renal transplant patients 6 and it is, on the other hand, lower than those obtained by
Borges-Costa, J. et al., whose value obtained was 24%. 12 In the present study, actinic keratosis was significantly associated with greater age, longer immunosuppression, azatoprine therapy and presence of history of cutaneous neoplasia. The risk of progression to malignant disease, which is proportional to the actinic damage, and the positive relationship between previous cutaneous neoplasia and the 640 Garrido PM, Borges-Costa J 16 and confirms the higher incidence of this disease in patients submitted to renal transplant, already identified in previous studies. 16 It should also be highlighted the interaction of immunosuppressive therapy with some of the diagnoses included in the group of inflammatory dermatoses, namely psoriasis and eczema, in which these drugs are used for therapeutic purposes, thus explaining their low incidence. 16 In this series, adverse drug reactions accounted for only 3.0% of referrals to the dermatology specialty. This value is significantly lower than that recorded in the study of Fernandes, S. et al.
(8.3% in the group of patients undergoing renal transplant) 6 and than that obtained in the study by Lally, A. et al., in which, although there was no total quantification of cutaneous lesions of iatrogenic nature, considerably higher values of some adverse drug reactions were observed, such as purpura (41%) and gingival hyperplasia (27%). 16 The lower reference rate observed in Portuguese studies, particularly in this series, may be the result of the effective treatment of these lesions by transplant teams, rather than a lower rate of occurrence. 6 The present study made it possible to emphasize the high prevalence of skin diseases in patients undergoing renal transplant.
These lesions have a strong impact on the quality of life of these patients, which may contribute to lower adherence to immunosuppressive therapy. 16 As such, it is important to recognize it and treat it properly and early, preferably in specialized centers.
CONCLUSION
The progressive increase in the longevity of patients undergoing renal transplant has modified the spectrum of skin diseases, making them therapeutic challenges of increasing complexity. The high incidence of lesions of a benign nature, namely infections, with strong impact on quality of life, and of cutaneous neoplasias, with associated morbidity, places particular relevance in the specialty of dermatology in the treatment of these patients. It is therefore crucial to ensure appropriate follow-up, with periodic evaluations from the pre-transplant stage. The main aim is ensure adherence to strategies to prevent skin cancer, promote early diagnosis and the effective treatment of various skin conditions. q
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